USD 15.97
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2024 | -7.55 Billion JPY | -148.18% |
2023 | 15.67 Billion JPY | -47.04% |
2022 | 29.59 Billion JPY | 69.45% |
2021 | 17.46 Billion JPY | 3485.27% |
2020 | -516 Million JPY | -108.08% |
2019 | 6.38 Billion JPY | 2384.82% |
2018 | 257 Million JPY | -22.82% |
2017 | 333 Million JPY | 106.55% |
2016 | -5.08 Billion JPY | -131.75% |
2015 | 16 Billion JPY | 4.44% |
2014 | 15.32 Billion JPY | 3.03% |
2013 | 14.87 Billion JPY | 20.79% |
2012 | 12.31 Billion JPY | 10.18% |
2011 | 11.17 Billion JPY | -3.56% |
2010 | 11.58 Billion JPY | 33.05% |
2009 | 8.7 Billion JPY | 4.97% |
2008 | 8.29 Billion JPY | -1.78% |
2007 | 8.44 Billion JPY | 4.75% |
2006 | 8.06 Billion JPY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 FY | -7.55 Billion JPY | -148.18% |
2024 Q1 | -1.12 Billion JPY | 64.02% |
2024 Q2 | -702 Million JPY | 37.32% |
2024 Q3 | -1.52 Billion JPY | -116.95% |
2024 Q4 | -4.2 Billion JPY | -176.3% |
2023 Q3 | 3.23 Billion JPY | -67.53% |
2023 FY | 15.67 Billion JPY | -47.04% |
2023 Q4 | -3.11 Billion JPY | -196.2% |
2023 Q1 | 5.58 Billion JPY | 36.9% |
2023 Q2 | 9.96 Billion JPY | 78.38% |
2022 Q1 | 8.34 Billion JPY | 75.72% |
2022 Q2 | 11.17 Billion JPY | 33.96% |
2022 FY | 29.59 Billion JPY | 69.45% |
2022 Q3 | 5.99 Billion JPY | -46.32% |
2022 Q4 | 4.08 Billion JPY | -31.97% |
2021 Q1 | -1.38 Billion JPY | 62.04% |
2021 Q4 | 4.74 Billion JPY | -37.67% |
2021 Q3 | 7.61 Billion JPY | 17.47% |
2021 FY | 17.46 Billion JPY | 3485.27% |
2021 Q2 | 6.48 Billion JPY | 568.91% |
2020 FY | -516 Million JPY | -108.08% |
2020 Q1 | 1.15 Billion JPY | 393.15% |
2020 Q2 | 1.38 Billion JPY | 20.26% |
2020 Q3 | 583 Million JPY | -58.03% |
2020 Q4 | -3.64 Billion JPY | -724.87% |
2019 Q4 | -394 Million JPY | -117.08% |
2019 Q3 | 2.3 Billion JPY | -12.25% |
2019 FY | 6.38 Billion JPY | 2384.82% |
2019 Q1 | 1.84 Billion JPY | 131.29% |
2019 Q2 | 2.62 Billion JPY | 42.57% |
2018 Q2 | -9.67 Billion JPY | -310.24% |
2018 Q4 | -5.89 Billion JPY | -152.52% |
2018 Q1 | 4.6 Billion JPY | 3701.65% |
2018 FY | 257 Million JPY | -22.82% |
2018 Q3 | 11.22 Billion JPY | 216.04% |
2017 Q2 | -7.08 Billion JPY | -456.78% |
2017 FY | 333 Million JPY | 106.55% |
2017 Q4 | 121 Million JPY | -97.72% |
2017 Q3 | 5.3 Billion JPY | 174.96% |
2017 Q1 | 1.98 Billion JPY | -59.32% |
2016 Q2 | 2.55 Billion JPY | -35.6% |
2016 Q1 | 3.96 Billion JPY | 59.46% |
2016 Q4 | 4.87 Billion JPY | 129.6% |
2016 Q3 | -16.48 Billion JPY | -744.95% |
2016 FY | -5.08 Billion JPY | -131.75% |
2015 Q1 | 3.25 Billion JPY | 10.78% |
2015 FY | 16 Billion JPY | 4.44% |
2015 Q4 | 2.48 Billion JPY | -53.49% |
2015 Q3 | 5.35 Billion JPY | 9.12% |
2015 Q2 | 4.9 Billion JPY | 50.52% |
2014 Q4 | 2.94 Billion JPY | -20.73% |
2014 FY | 15.32 Billion JPY | 3.03% |
2014 Q1 | 4.23 Billion JPY | 40.53% |
2014 Q2 | 4.44 Billion JPY | 4.99% |
2014 Q3 | 3.71 Billion JPY | -16.46% |
2013 Q2 | 3.63 Billion JPY | -19.13% |
2013 Q4 | 3.01 Billion JPY | -19.32% |
2013 FY | 14.87 Billion JPY | 20.79% |
2013 Q1 | 4.49 Billion JPY | 88.31% |
2013 Q3 | 3.73 Billion JPY | 2.64% |
2012 FY | 12.31 Billion JPY | 10.18% |
2012 Q2 | 3.57 Billion JPY | -2.24% |
2012 Q3 | 2.68 Billion JPY | -24.85% |
2012 Q4 | 2.38 Billion JPY | -11.2% |
2012 Q1 | 3.65 Billion JPY | 108.37% |
2011 Q4 | 1.75 Billion JPY | -41.62% |
2011 FY | 11.17 Billion JPY | -3.56% |
2011 Q1 | 3.1 Billion JPY | 62.14% |
2011 Q3 | 3 Billion JPY | -8.96% |
2011 Q2 | 3.3 Billion JPY | 6.41% |
2010 Q3 | 2.99 Billion JPY | -16.94% |
2010 Q1 | 3.08 Billion JPY | 32.08% |
2010 Q4 | 1.91 Billion JPY | -35.95% |
2010 FY | 11.58 Billion JPY | 33.05% |
2010 Q2 | 3.6 Billion JPY | 16.88% |
2009 Q4 | 2.33 Billion JPY | -2.06% |
2009 Q3 | 2.38 Billion JPY | 2.1% |
2009 Q2 | 2.33 Billion JPY | 0.0% |
2009 FY | 8.7 Billion JPY | 4.97% |
2008 FY | 8.29 Billion JPY | -1.78% |
2007 FY | 8.44 Billion JPY | 4.75% |
2006 FY | 8.06 Billion JPY | 0.0% |
2005 Q4 | - JPY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
American Bio Medica Corporation | -1.41 Million USD | -535573.759% |
Arrayit Corporation | -3.31 Million USD | -227702.318% |
Atlantic International Corp. | -5.62 Million USD | -134113.734% |
Biocept, Inc. | -32.08 Million USD | -23439.128% |
Bioqual, Inc. | 483.48 Thousand USD | 1562312.372% |
CardioGenics Holdings Inc | -1.91 Million USD | -394040.031% |
DermTech, Inc. | -100.88 Million USD | -7386.52% |
Global WholeHealth Partners Corporation | - USD | Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 473.015% |
HTG Molecular Diagnostics, Inc. | -21.59 Million USD | -34876.538% |
iMD Companies, Inc. | -200.63 Thousand USD | -3764428.798% |
IDenta Corp. | 14.64 Thousand USD | 51577537.859% |
Interpace Biosciences, Inc. | 802 Thousand USD | 941870.574% |
Integrative Health Technologies, Inc. | 38.68 Thousand USD | 19522444.853% |
InVitro International | 1553.00 USD | 486349101.932% |
Lumos Diagnostics Holdings Limited | -8.59 Million USD | -87807.356% |
Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -12997215.529% |
Medical Imaging Corp. | -3.02 Million USD | -249749.158% |
NovelStem International Corp. | -4.18 Million USD | -180278.764% |
Optigenex Inc. | -2.89 Million USD | -260549.605% |
PharmChem, Inc. | 845.1 Thousand USD | 893838.271% |
Proteome Sciences plc | -2.44 Million USD | -309069.054% |
Response Genetics, Inc | -20.18 Million USD | -37320.729% |
Rennova Health, Inc. | -3.29 Million USD | -229261.49% |
RushNet, Inc. | -607.02 Thousand USD | -1244158.914% |
ScreenPro Security Inc. | -2.24 Million USD | -335772.947% |
Stella Diagnostics Inc. | -5.7 Million USD | -132236.317% |
StageZero Life Sciences Ltd. | -11.41 Million USD | -66065.167% |
Todos Medical Ltd. | -24.99 Million USD | -30119.253% |